FeesSafety
Pluang+

MiniMed gets FDA clearance for MiniMed Fit, a tubeless insulin pump with 7-day wear and app control.

Market News
16 Nov 2026, 16:05 WIB
PRNewsWire
View Source
Bullish
MiniMed gets FDA clearance for MiniMed Fit, a tubeless insulin pump with 7-day wear and app control.

MiniMed has received FDA clearance for MiniMed Fit, its first tubeless insulin pump designed for people with diabetes. The device offers up to seven days of wear without charging or cartridge changes, a 300-unit insulin capacity, and app control via iOS and Android. It features SmartGuard technology for automated insulin delivery and Meal Detection to improve glucose control. The pump will launch in the U.S. in spring 2027, providing a more convenient and advanced option for diabetes management through pharmacy availability.

MiniMed Group Inc. (MMED) has a market cap of $5.06 billion and an enterprise value of $4.86 billion as of Nov 16, 2026, 21:21 WIB. The stock is trading at USD 18.88 with a notable 1-day gain of 4.95%, supported by a high trading volume of 5,376,895 shares on Pluang. This strong market activity coincides with the recent FDA clearance news, reflecting investor interest in the company's innovative diabetes management technology.

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App